A Primary Care–Based Weight Navigation Program
Authors' conclusion
The findings of this cohort study suggest that WNP is feasible and associated with greater WMT use and weight loss than matched controls. The WNP warrants evaluation in a large-scale trial.
Study context
- Population
- Adults with obesity and ≥1 weight-related condition from intervention and control sites, large academic health system, Midwestern US; 68.6% female, mean age 49.5 yearspropensity matched
- Participants
- 264 adults
- Exposure
- Primary care–based weight navigation program vs matched controls
- Weight navigation program (WNP)n = 132
- Matched controlsn = 132reference
- Outcome
- Feasibility measures, including rates of referral to and engagement in the WNP
Methodological detailsevaluation of a quality improvement program, propensity matched, difference-in-differences analysis, Program conducted October 1, 2020, to September 30, 2021
- Evaluation of a quality improvement program
- Propensity matched
- Difference-in-differences analysis
- Program conducted October 1, 2020, to September 30, 2021
Main finding
As reported in the abstract
Feasibility among 1159 WNP-eligible patients
Referred to the WNP
219
18.9%
Completed a WNP visit
132
11.4%
Observational data: associations, not effects.
Secondary outcomes
| Outcome | Difference (kg) (95% CI) | P value | |
|---|---|---|---|
| Weight loss (kg) · 12 monthsGreater weight loss with WNP; difference-in-differences | 4.9 (2.11–7.76) | P < 0.001 | |
| −50510Difference, kg (linear scale) |
| Outcome | Difference (95% CI) | P value | |
|---|---|---|---|
| Percentage weight loss · 12 monthsGreater weight loss with WNP | 4.4% (2.2%–6.4%) | P < 0.001 | |
| −50510Difference (linear scale) |
| Outcome | OR (95% CI) | |
|---|---|---|
| ≥5% weight loss · 12 months | 2.90 (1.54–5.58) | |
| ≥10% weight loss · 12 months | 7.19 (2.55–25.9) | |
| 0.050.21520Odds ratio (log scale) |
Referral to bariatric surgery
P = 0.02
Referral to low-calorie meal replacement program
P < 0.001
Referral to Mediterranean-style diet and activity program
P = 0.002
| Outcome | Average marginal effects (95% CI) |
|---|---|
| ≥5% weight loss · 12 months | 21.2% (8.8%–33.6%) |
| ≥10% weight loss · 12 months | 17.4% (8.7%–26.2%) |
Antiobesity medication prescribing
- No between-group differences in antiobesity medication prescribing
Original publication
A Primary Care–Based Weight Navigation Program. JAMA Netw Open. Published 1 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →